BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $925 | +47.3% | 322,246 | +159.1% | 0.00% | – |
Q2 2023 | $628 | +1597.3% | 124,351 | +542.6% | 0.00% | – |
Q1 2023 | $37 | +5.7% | 19,351 | 0.0% | 0.00% | – |
Q4 2022 | $35 | -99.9% | 19,351 | -7.6% | 0.00% | – |
Q3 2022 | $35,000 | -35.2% | 20,935 | -4.8% | 0.00% | – |
Q2 2022 | $54,000 | -26.0% | 21,992 | -16.6% | 0.00% | – |
Q1 2022 | $73,000 | – | 26,380 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 3,449,845 | $86,074,000 | 4.50% |
Boxer Capital, LLC | 2,014,858 | $50,271,000 | 3.43% |
RA Capital Management | 2,589,904 | $64,618,000 | 2.04% |
Artal Group S.A. | 1,696,517 | $42,328,000 | 1.79% |
Logos Global Management LP | 123,465 | $2,772,000 | 1.05% |
BVF INC/IL | 378,788 | $9,451,000 | 0.88% |
Casdin Capital, LLC | 289,395 | $7,220,000 | 0.77% |
Perceptive Advisors | 1,104,656 | $27,561,000 | 0.72% |
Bellevue Group AG | 1,330,000 | $33,184,000 | 0.64% |
Vivo Capital, LLC | 252,119 | $6,290,000 | 0.57% |